Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2020: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | Accelerate Diagnostics, Inc.✕ AXDX | DermTech, Inc.✕ DMTK |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1987 | 1995 |
| Size | ||
| Revenue | ||
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | Accelerate Diagnostics, Inc. | DermTech, Inc. |
|---|---|---|
| 2024 | $12 MSEC | — |
| 2023 | $12 MSEC | — |
| 2022 | $13 MSEC | — |
| 2021 | $12 MSEC | — |
| 2020 | $11 MSEC | — |
| 2019 | $9 MSEC | — |
| 2018 | $6 MSEC | — |
| 2017 | $4 MSEC | — |
| 2016 | $0 MSEC | — |
| 2015 | $0 MSEC | — |
| 2014 | $0 MSEC | — |
| 2013 | $0 MSEC | — |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $12 M |
| $6 M |
| Net income | $-50 M | $-35 M▲ best |
|---|
| Employees | 275 | — |
|---|
| Profitability | ||
|---|---|---|
| Gross margin | 23.1% | — |
| Operating margin | -301.8% | — |
| Net margin | -427.7% | — |
| Growth | ||
|---|---|---|
| Revenue growth | -3.0% | — |
| Revenue growth, 3 years a year | -0.2% | — |
| Cash | ||
|---|---|---|
| Free cash flow margin | -211.1% | — |
| Altman Z-score zone | — | — |
|---|
| Data as of | Market cap Jan 2024; ratios FY2024 | Market cap Jan 2024 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.